1. A first Czech analysis of 1887 cases with monoclonal gammopathy of undetermined significance. (11th May 2017) Authors: Sandecká, Viera; Hájek, Roman; Pour, Luděk; Špička, Ivan; Ščudla, Vlastimil; Gregora, Evžen; Radocha, Jakub; Walterová, Lenka; Kessler, Petr; Zahradová, Lenka; Adamová, Dagmar; Valentova, Kamila; Vonke, Ivan; Obernauerová, Jarmila; Starostka, David; Wróbel, Marek; Brožová, Lucie; Jarkovský, Jiří;... Journal: European journal of haematology Issue: Volume 99:Number 1(2017) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Activity of aldehyde dehydrogenase in B‐cell and plasma cell subsets of monoclonal gammopathy patients and healthy donors. (9th June 2016) Authors: Všianská, Pavla; Bezděková, Renata; Kryukov, Fedor; Almáši, Martina; Pour, Luděk; Penka, Miroslav; Hájek, Roman; Říhová, Lucie Journal: European journal of haematology Issue: Volume 98:Number 1(2017:Jan.) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients. (4th May 2018) Authors: Jelínek, Tomáš; Maisnar, Vladimír; Pour, Luděk; Špička, Ivan; Minařík, Jiří; Gregora, Evžen; Kessler, Petr; Sýkora, Michal; Fraňková, Hana; Adamová, Dagmar; Wróbel, Marek; Mikula, Peter; Jarkovský, Jiří; Diels, Joris; Gatopoulou, Xenia; Veselá, Šárka; Besson, Hervé; Brožová, Lucie; Ito, Tetsuro; ... Journal: Current medical research and opinion Issue: Volume 34:Number 5(2018) Page Start: 775 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bortezomib‐based therapy for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplantation: Czech Registry Data. (28th July 2021) Authors: Sandecká, Viera; Pour, Luděk; Špička, Ivan; Minařík, Jiří; Radocha, Jakub; Jelínek, Tomáš; Heindorfer, Adriana; Pavlíček, Petr; Sýkora, Michal; Jungová, Alexandra; Kessler, Petr; Wróbel, Marek; Starostka, David; Ullrychová, Jana; Stejskal, Lukáš; Štork, Martin; Straub, Jan; Pika, Tomáš; Brožová, ... Journal: European journal of haematology Issue: Volume 107:Number 4(2021) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study. Issue 1 (January 2016) Authors: Dimopoulos, Meletios A; Moreau, Philippe; Palumbo, Antonio; Joshua, Douglas; Pour, Ludek; Hájek, Roman; Facon, Thierry; Ludwig, Heinz; Oriol, Albert; Goldschmidt, Hartmut; Rosiñol, Laura; Straub, Jan; Suvorov, Aleksandr; Araujo, Carla; Rimashevskaya, Elena; Pika, Tomas; Gaidano, Gianluca; Weisel,... Journal: Lancet oncology Issue: Volume 17:Issue 1(2016:Feb.) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup. Issue 10 (3rd October 2017) Authors: Ludwig, Heinz; Dimopoulos, Meletios A.; Moreau, Philippe; Chng, Wee-Joo; Goldschmidt, Hartmut; Hájek, Roman; Facon, Thierry; Pour, Ludek; Niesvizky, Ruben; Oriol, Albert; Rosiñol, Laura; Suvorov, Aleksandr; Gaidano, Gianluca; Pika, Tomas; Weisel, Katja; Goranova-Marinova, Vesselina; Palumbo, Anto... Journal: Leukemia & lymphoma Issue: Volume 58:Issue 10(2017) Page Start: 2501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study. (17th February 2017) Authors: Dimopoulos, Meletios A.; Stewart, A. Keith; Masszi, Tamás; Špička, Ivan; Oriol, Albert; Hájek, Roman; Rosiñol, Laura; Siegel, David; Mihaylov, Georgi G.; Goranova‐Marinova, Vesselina; Rajnics, Péter; Suvorov, Aleksandr; Niesvizky, Ruben; Jakubowiak, Andrzej; San‐Miguel, Jesus; Ludwig, Heinz; Palu... Journal: British journal of haematology Issue: Volume 177:Number 3(2017) Page Start: 404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases. (June 2013) Authors: Adam, Zdeněk; Szturz, Petr; Vaníček, Jiří; Moulis, Mojmír; Pour, Luděk; Krejčí, Marta; Hájek, Roman; Mayer, Jiří Journal: Acta oncologica Issue: Volume 52:Number 5(2013) Page Start: 994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment. Issue 6 (1st June 2013) Authors: Szturz, Petr; Adam, Zdeněk; Vašků, Vladimír; Feit, Josef; Krejčí, Marta; Pour, Luděk; Hájek, Roman; Mayer, Jiří Journal: Leukemia & lymphoma Issue: Volume 54:Issue 6(2013:Jun.) Page Start: 1324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment. Issue 6 (June 2013) Authors: Szturz, Petr; Adam, Zdeněk; Vašků, Vladimír; Feit, Josef; Krejčí, Marta; Pour, Luděk; Hájek, Roman; Mayer, Jiří Journal: Leukemia & lymphoma Issue: Volume 54:Issue 6(2013:Jun.) Page Start: 1324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗